Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

496 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Active, Not Recruiting

A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

NCT06544330

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Feinstein Institutes for Medical Research Manhasset, New York, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Active, Not Recruiting

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

NCT07219121

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cornell Medical Center New York, United States
  • University of North Carolina Chapel Hill Morrisville, North Carolina, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

NCT06291376

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +20 more
Locations
  • Research Site Alabaster, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 246 locations
View Trial Details
Active, Not Recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases

NCT04573920

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +26 more
Locations
  • Kidney Disease Medical Group Glendale, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • North America Research Institute San Dimas, California, United States
  • Stanford U School Of Medicine Stanford, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

NCT05126277

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Advanced Medical Research La Palma, California, United States
  • University of California Irvine Orange, California, United States
  • School Of Medicine Sacramento, California, United States
View all 156 locations
View Trial Details
Active, Not Recruiting

A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

NCT03762850

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Travere Investigational Site Birmingham, Alabama, United States
  • Travere Investigational Site Homewood, Alabama, United States
  • Travere Investigational Site Glendale, California, United States
  • Travere Investigational Site Montebello, California, United States
View all 162 locations
View Trial Details

Related conditions